Mutual Pharmaceutical Recalls Felodipine Tablets Due to Chemical Contamination
Mutual Pharmaceutical is recalling specific lots of Felodipine Extended-Release Tablets because benzophenone leached from the product label varnish.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this recall as Class III, which by definition is unlikely to cause adverse health consequences, aligning with the 'Low' severity criteria for minor issues.
Plain-English summary
Mutual Pharmaceutical Company, Inc. is recalling 97,859 bottles of Felodipine Extended-Release Tablets, 5 mg, 100 count bottles. The affected product is prescription-only and was distributed nationwide. The recall involves specific lot numbers with expiration dates ranging from October 2015 to August 2016.
The recall was initiated due to chemical contamination. Specifically, benzophenone was found to have leached from the product label varnish. The U.S. Food and Drug Administration has classified this recall as Class III, indicating that use of or exposure to the violative product is not likely to cause adverse health consequences.
Consumers who have these specific bottles should stop using the medication and contact their healthcare provider or pharmacist for guidance on obtaining a replacement. The affected lots are identified by the following numbers and expiration dates: 6662801 (exp 10/15), 6662901 (exp 10/15), 6689601 (exp 4/16), 6689701 (exp 5/16), and 6708401 (exp 8/16).
The recalled product
- Product
- Felodipine Extended-Release Tablets, 5 mg, 100 count bottles, Rx only, Mutual Pharmaceutical Co. Inc., Philadelphia, PA --- NDC 53489-369-01
- Manufacturer
- Mutual Pharmaceutical Company, Inc.
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 97,859
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- lot #s: 6662801 & 6662901
- exp 10/15
- 6689601
- exp 4/16
- 6689701
- exp 5/16 and 6708401
- 8/16
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 6 recalled by Mutual Pharmaceutical Company, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 6 products in this recall →Related recalls
Same manufacturer · Mutual Pharmaceutical Company, Inc.
See all →- ModerateMutual Pharmaceutical Recalls Sulfamethoxazole and Trimethoprim Tablets Due to Foreign Substance
FDA (Drugs) · 2016-01-27
- LowMutual Pharmaceutical Recalls Imipramine HCl Tablets Due to Chemical Contamination
FDA (Drugs) · 2015-09-16
- ModerateMutual Pharmaceutical Recalls Imipramine HCl Tablets Due to Chemical Contamination
FDA (Drugs) · 2015-09-16
- LowMutual Pharmaceutical Recalls Felodipine Tablets Due to Chemical Contamination
FDA (Drugs) · 2015-09-16
- ModerateMutual Pharmaceutical Recalls Imipramine HCl Tablets Due to Benzophenone Contamination
FDA (Drugs) · 2015-09-16
Same hazard · chemical contamination
See all →- SevereAmerican Regent Recalls Acetylcysteine Solution Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereGas-X Extra Strength softgels contaminated with propylene glycol machine coolant
FDA (Drugs) · 2026-06-17
- HighDragonfly Thai ginger powder may be contaminated with lead
FDA (Food) · 2026-06-17
- SevereNaproxen Oral Suspension Recalled for Lead and Lithium Contamination
FDA (Drugs) · 2026-05-13
- HighFarmHouse Fresh benzoyl peroxide night lotion recalled over benzene contamination
FDA (Drugs) · 2026-04-22